Rebecca Napier, MD
Advanced Heart Failure and Transplant Cardiology · Columbia, SCNPI 1730317314
Payments from drug & device makers
Across 553 payments — averaging $424.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$198K
- Novartis$30K
- Alnylam Pharmaceuticals Inc.$899
- AstraZeneca$700
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$699
- Boston Scientific$666
- plus $4K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 165 | $198,157 |
| Novartis | 76 | $29,662 |
| Alnylam Pharmaceuticals Inc. | 48 | $899 |
| AstraZeneca | 27 | $700 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 42 | $699 |
| Boston Scientific | 30 | $666 |
| Pfizer | 22 | $514 |
| Actelion Pharmaceuticals US, Inc. | 27 | $470 |
| Merck | 19 | $452 |
| Cvrx, Inc. | 9 | $348 |
| Boehringer Ingelheim | 18 | $341 |
| E.r. Squibb & Sons, L.L.C. | 14 | $313 |
| Bayer | 13 | $235 |
| Philips North America LLC | 2 | $223 |
| Lexicon Pharmaceuticals, Inc. | 2 | $139 |
| Abiomed | 2 | $134 |
| Impulse Dynamics (USA) Inc. | 1 | $127 |
| Edwards Lifesciences | 1 | $121 |
| Novo Nordisk | 6 | $120 |
| Scpharmaceuticals Inc. | 6 | $104 |
| Medtronic(2 entities) | 5 | $96 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Johnson & Johnson | 6 | $74 |
| Ancora Heart, Inc. | 1 | $49 |
| Nuwellis, Inc. | 1 | $45 |
| Bridgebio Pharma, Inc. | 1 | $32 |
| Livanova USA, Inc. | 2 | $28 |
| Recor Medical Inc | 1 | $25 |
| Endotronix, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
How this compares
$234,885 in reported general payments places this provider in the 65th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
See all advanced heart failure and transplant cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Columbia
- Patrick McCannColumbia$1.4M
- James AmpaduColumbia$207K
- Cassandra Buto-CollettiColumbia$21K
- Joshua ConeyColumbia$14K
- Barry FeldmanColumbia$12K
- Michael RofaelColumbia$11K
- Jason GuichardGreenville$4.3M
- Daniel SilvermanCharleston$1.2M
- Sheldon LitwinCharleston$1.1M
- Ryan TedfordCharleston$590K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.